Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aged garlic extract (AGE) is a dietary supplement produced by aging fresh garlic bulbs for at least 20 months at room temperature. This process converts unstable sulfur compounds in raw garlic, such as allicin, into more stable and bioavailable compounds like S-allylcysteine (SAC). AGE is claimed to have cardiovascular benefits including reducing blood pressure and arterial stiffness, improving cholesterol profiles, and exerting anti-inflammatory effects. Its mechanisms of action are thought to include stimulation of nitric oxide and hydrogen sulfide production leading to vasodilation, as well as inhibition of angiotensin-converting enzyme production. AGE also has antioxidant properties and may provide additional health benefits such as supporting immune function and reducing the risk of certain cancers. It is generally considered safe with fewer adverse effects than other forms of garlic supplements[1][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aged garlic extract.